385 related articles for article (PubMed ID: 22177841)
1. Structure-property relationships in manganese oxide--mesoporous silica nanoparticles used for T1-weighted MRI and simultaneous anti-cancer drug delivery.
Chen Y; Chen H; Zhang S; Chen F; Sun S; He Q; Ma M; Wang X; Wu H; Zhang L; Zhang L; Shi J
Biomaterials; 2012 Mar; 33(7):2388-98. PubMed ID: 22177841
[TBL] [Abstract][Full Text] [Related]
2. Manganese oxide-based multifunctionalized mesoporous silica nanoparticles for pH-responsive MRI, ultrasonography and circumvention of MDR in cancer cells.
Chen Y; Yin Q; Ji X; Zhang S; Chen H; Zheng Y; Sun Y; Qu H; Wang Z; Li Y; Wang X; Zhang K; Zhang L; Shi J
Biomaterials; 2012 Oct; 33(29):7126-37. PubMed ID: 22789722
[TBL] [Abstract][Full Text] [Related]
3. Mesoporous manganese silicate coated silica nanoparticles as multi-stimuli-responsive T1-MRI contrast agents and drug delivery carriers.
Li X; Zhao W; Liu X; Chen K; Zhu S; Shi P; Chen Y; Shi J
Acta Biomater; 2016 Jan; 30():378-387. PubMed ID: 26602820
[TBL] [Abstract][Full Text] [Related]
4. Composition-property relationships in multifunctional hollow mesoporous carbon nanosystems for PH-responsive magnetic resonance imaging and on-demand drug release.
Zhang S; Qian X; Zhang L; Peng W; Chen Y
Nanoscale; 2015 May; 7(17):7632-43. PubMed ID: 25785502
[TBL] [Abstract][Full Text] [Related]
5. Fabrication and evaluation of tumor-targeted positive MRI contrast agent based on ultrasmall MnO nanoparticles.
Huang H; Yue T; Xu K; Golzarian J; Yu J; Huang J
Colloids Surf B Biointerfaces; 2015 Jul; 131():148-54. PubMed ID: 25982318
[TBL] [Abstract][Full Text] [Related]
6. Manganese-impregnated mesoporous silica nanoparticles for signal enhancement in MRI cell labelling studies.
Guillet-Nicolas R; Laprise-Pelletier M; Nair MM; Chevallier P; Lagueux J; Gossuin Y; Laurent S; Kleitz F; Fortin MA
Nanoscale; 2013 Dec; 5(23):11499-511. PubMed ID: 24178890
[TBL] [Abstract][Full Text] [Related]
7. Ternary-Responsive Drug Delivery with Activatable Dual Mode Contrast-Enhanced in Vivo Imaging.
Ren S; Yang J; Ma L; Li X; Wu W; Liu C; He J; Miao L
ACS Appl Mater Interfaces; 2018 Sep; 10(38):31947-31958. PubMed ID: 30179443
[TBL] [Abstract][Full Text] [Related]
8. L-DOPA-Coated Manganese Oxide Nanoparticles as Dual MRI Contrast Agents and Drug-Delivery Vehicles.
McDonagh BH; Singh G; Hak S; Bandyopadhyay S; Augestad IL; Peddis D; Sandvig I; Sandvig A; Glomm WR
Small; 2016 Jan; 12(3):301-6. PubMed ID: 26619158
[TBL] [Abstract][Full Text] [Related]
9. One-pot preparation of hydrophilic manganese oxide nanoparticles as T
Li J; Wu C; Hou P; Zhang M; Xu K
Biosens Bioelectron; 2018 Apr; 102():1-8. PubMed ID: 29101783
[TBL] [Abstract][Full Text] [Related]
10. Luminescent GdVO4:Eu3+ functionalized mesoporous silica nanoparticles for magnetic resonance imaging and drug delivery.
Huang S; Cheng Z; Ma P; Kang X; Dai Y; Lin J
Dalton Trans; 2013 May; 42(18):6523-30. PubMed ID: 23474744
[TBL] [Abstract][Full Text] [Related]
11. "Manganese Extraction" Strategy Enables Tumor-Sensitive Biodegradability and Theranostics of Nanoparticles.
Yu L; Chen Y; Wu M; Cai X; Yao H; Zhang L; Chen H; Shi J
J Am Chem Soc; 2016 Aug; 138(31):9881-94. PubMed ID: 27441571
[TBL] [Abstract][Full Text] [Related]
12. Biocompatible mesoporous silica-coated superparamagnetic manganese ferrite nanoparticles for targeted drug delivery and MR imaging applications.
Sahoo B; Devi KS; Dutta S; Maiti TK; Pramanik P; Dhara D
J Colloid Interface Sci; 2014 Oct; 431():31-41. PubMed ID: 24980623
[TBL] [Abstract][Full Text] [Related]
13. Advances in Functionalized Mesoporous Silica Nanoparticles for Tumor Targeted Drug Delivery and Theranostics.
Zhang W; Liu M; Liu A; Zhai G
Curr Pharm Des; 2017; 23(23):3367-3382. PubMed ID: 27784244
[TBL] [Abstract][Full Text] [Related]
14. Silica-F127 nanohybrid-encapsulated manganese oxide nanoparticles for optimized T1 magnetic resonance relaxivity.
Wei Hsu BY; Wang M; Zhang Y; Vijayaragavan V; Wong SY; Yuang-Chi Chang A; Bhakoo KK; Li X; Wang J
Nanoscale; 2014 Jan; 6(1):293-9. PubMed ID: 24193096
[TBL] [Abstract][Full Text] [Related]
15. PSA targeted dual-modality manganese oxide-mesoporous silica nanoparticles for prostate cancer imaging.
Du D; Fu HJ; Ren WW; Li XL; Guo LH
Biomed Pharmacother; 2020 Jan; 121():109614. PubMed ID: 31731188
[TBL] [Abstract][Full Text] [Related]
16. Enzyme responsive drug delivery system based on mesoporous silica nanoparticles for tumor therapy in vivo.
Liu Y; Ding X; Li J; Luo Z; Hu Y; Liu J; Dai L; Zhou J; Hou C; Cai K
Nanotechnology; 2015 Apr; 26(14):145102. PubMed ID: 25789511
[TBL] [Abstract][Full Text] [Related]
17. Real-time monitoring of arsenic trioxide release and delivery by activatable T(1) imaging.
Zhao Z; Wang X; Zhang Z; Zhang H; Liu H; Zhu X; Li H; Chi X; Yin Z; Gao J
ACS Nano; 2015 Mar; 9(3):2749-59. PubMed ID: 25688714
[TBL] [Abstract][Full Text] [Related]
18. A Prussian Blue-Based Core-Shell Hollow-Structured Mesoporous Nanoparticle as a Smart Theranostic Agent with Ultrahigh pH-Responsive Longitudinal Relaxivity.
Cai X; Gao W; Ma M; Wu M; Zhang L; Zheng Y; Chen H; Shi J
Adv Mater; 2015 Nov; 27(41):6382-9. PubMed ID: 26393889
[TBL] [Abstract][Full Text] [Related]
19. Manganese oxide and docetaxel co-loaded fluorescent polymer nanoparticles for dual modal imaging and chemotherapy of breast cancer.
Abbasi AZ; Prasad P; Cai P; He C; Foltz WD; Amini MA; Gordijo CR; Rauth AM; Wu XY
J Control Release; 2015 Jul; 209():186-96. PubMed ID: 25908171
[TBL] [Abstract][Full Text] [Related]
20. Tailored Mesoporous Silica Nanoparticles for Controlled Drug Delivery: Platform Fabrication, Targeted Delivery, and Computational Design and Analysis.
She X; Chen L; Yi Z; Li C; He C; Feng C; Wang T; Shigdar S; Duan W; Kong L
Mini Rev Med Chem; 2018; 18(11):976-989. PubMed ID: 27145854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]